Back to search
FDAFDA · Food and drugs·Recall number Z-2087-2018

ST-AIA PACK Prolactin; Part Number: 025255 Assay, Reproductive Hormone

Published June 13, 2018 · Recall initiated: March 5, 2018

Summary

FDA records medical device Class II recall Z-2087-2018, published June 13, 2018 and initiated March 5, 2018. Recalling firm: Tosoh Bioscience Inc; Status: Terminated; Reported quantity: 4867; Lot: All Lot Codes. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tosoh Bioscience Inc
Distributor
Worldwide Distribution: US (Nationwide) and countries of; Canada, Mexico, Columbia, Chile, Uruguay, Nicaragua, Argentina, Peru, Chile, Honduras. Equador, Caymen Islands, Panama, and Costa Rica.
Lot
All Lot Codes
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ST-AIA PACK Prolactin; Part Number: 025255 Assay, Reproductive Hormone recalled?

Yes. FDA published recall Z-2087-2018 on June 13, 2018. Reported hazard: Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter